Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross Fasano

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cancer Reports (Hoboken, N.J.)|July 6, 2022
Characteristics and outcomes of pediatric oncology patients at risk for guardians declining transfusion of blood componentsJason Stevenson, Nicholas P DeGroote, Frank Keller, et al.
Transfusion Medicine Reviews|August 20, 2023
Prophylactic Platelet Transfusion: Is There Evidence of Benefit, Harm, or No Effect?Cheryl L Maier, Simon J Stanworth, Martha Sola-Visner, et al.
Human Immunology|October 18, 2015
Protective effect of HLA-DQB1 alleles against alloimmunization in patients with sickle cell diseaseZohreh Tatari-Calderone, Heather Gordish-Dressman, Ross Fasano, et al.
Transfusion|February 5, 2024
Results of clinical effectiveness of conventional versus Mirasol-treated Apheresis Platelets in Patients with Hypoproliferative Thrombocytopenia (MiPLATE) trialScott A Koepsell, Moritz Stolla, Rebecca L Sedjo, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 14, 2019
Challenges in preventing and treating hemolytic complications associated with red blood cell transfusionSatheesh Chonat, Connie M Arthur, Patricia E Zerra, et al.
Blood Advances|January 26, 2021
Antigen density dictates RBC clearance, but not antigen modulation, following incompatible RBC transfusion in miceConnie M Arthur, Jerry William L Allen, Hans Verkerke, et al.
Trials|May 26, 2026
A randomized, double-blind, controlled, parallel group study with amustaline/glutathione pathogen reduced red blood cells in regions at potential risk for Zika virus transfusion-transmitted infections (RedeS Study)-protocol for a phase 3 clinical trialEdgardo F Cartagena Ayala, Lumen Vera Colon, Yesim Aydinok, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cancer Reports (Hoboken, N.J.)|July 6, 2022
Characteristics and outcomes of pediatric oncology patients at risk for guardians declining transfusion of blood componentsJason Stevenson, Nicholas P DeGroote, Frank Keller, et al.
Transfusion Medicine Reviews|August 20, 2023
Prophylactic Platelet Transfusion: Is There Evidence of Benefit, Harm, or No Effect?Cheryl L Maier, Simon J Stanworth, Martha Sola-Visner, et al.
Human Immunology|October 18, 2015
Protective effect of HLA-DQB1 alleles against alloimmunization in patients with sickle cell diseaseZohreh Tatari-Calderone, Heather Gordish-Dressman, Ross Fasano, et al.
Transfusion|February 5, 2024
Results of clinical effectiveness of conventional versus Mirasol-treated Apheresis Platelets in Patients with Hypoproliferative Thrombocytopenia (MiPLATE) trialScott A Koepsell, Moritz Stolla, Rebecca L Sedjo, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 14, 2019
Challenges in preventing and treating hemolytic complications associated with red blood cell transfusionSatheesh Chonat, Connie M Arthur, Patricia E Zerra, et al.
Blood Advances|January 26, 2021
Antigen density dictates RBC clearance, but not antigen modulation, following incompatible RBC transfusion in miceConnie M Arthur, Jerry William L Allen, Hans Verkerke, et al.
Trials|May 26, 2026
A randomized, double-blind, controlled, parallel group study with amustaline/glutathione pathogen reduced red blood cells in regions at potential risk for Zika virus transfusion-transmitted infections (RedeS Study)-protocol for a phase 3 clinical trialEdgardo F Cartagena Ayala, Lumen Vera Colon, Yesim Aydinok, et al.
Pageof 2